Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C8166)
◆英語タイトル:Crescita Therapeutics Inc (CTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8166
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premiology and ISDIN. Its Pliaglis is a local anesthetic cream for superficial dermatological and cosmetic procedures. Crescita Therapeutics develops Mical used in therapeutic areas of psoriasis and dermatological skin treatment. The company develops products using drug delivery platforms which include multiplexed molecular penetration enhancers and DuraPeel. It markets products in the US, Canada and Mexico. Crescita Therapeutics is headquartered in Laval, Ontario, Canada.

Crescita Therapeutics Inc (CTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
INTEGA Skin Sciences Acquires Alyria Skincare Product Line from Sanofi Consumer Health for USD1.3 Million 11
Licensing Agreements 12
Taro Pharma Enters into Licensing Agreement with Crescita Therapeutics 12
Crescita Therapeutics Enters into Licesning Agreement with US Contract Research Company 13
Dermatological Contract Research Company Enters into Licensing Agreement with Crescita Therapeutics 14
Knight Therapeutics Enters into Licensing Agreement with INTEGA Skin Sciences 15
Equity Offering 16
Crescita Therapeutics Raises USD3.7 Million in Rights Offering of Shares 16
Debt Offering 17
Crescita Therapeutics Raises USD0.7 Million in Private Placement of 9% Convertible Debenture 17
Asset Transactions 18
Crescita Therapeutics Divests Manufacturing Facility in Germany 18
Acquisition 19
Knight Therapeutics Acquires 4% Stake in Crescita Therapeutics 19
Crescita Therapeutics Acquires Intega Skin Sciences for USD7.6 Million 20
Crescita Therapeutics Inc – Key Competitors 21
Crescita Therapeutics Inc – Key Employees 22
Crescita Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 10, 2018: Crescita Therapeutics reports 2018 second quarter results 24
May 09, 2018: Crescita Therapeutics Reports 2018 First Quarter Results 27
Mar 28, 2018: Crescita Therapeutics Reports 2017 Fourth Quarter and Year End Results 29
Nov 10, 2017: Crescita Therapeutics Announces 2017 Third Quarter Results and Appoints New CFO 31
Aug 14, 2017: Crescita Therapeutics Announces Profitable 2017 Second Quarter Results 33
May 15, 2017: Crescita Therapeutics Announces 2017 First Quarter Results 35
Mar 30, 2017: Crescita Therapeutics Announces 2016 Fourth Quarter and Year-End Results 37
Corporate Communications 39
Apr 03, 2018: Crescita Therapeutics Announces the Appointment of Serge Verreault as President & CEO 39
Apr 12, 2017: Crescita Therapeutics Announces the Appointment of a New President 40
Feb 10, 2017: Crescita Therapeutics Announces Management and Board Changes 41
Product News 42
Jan 26, 2017: Crescita Therapeutics Announces Launch of ISDIN Product Line at Brunet Pharmacy 42
Other Significant Developments 43
Oct 15, 2018: Crescita’s patented delivery technologies demonstrate enhanced skin permeation of cannabidiol 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crescita Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
INTEGA Skin Sciences Acquires Alyria Skincare Product Line from Sanofi Consumer Health for USD1.3 Million 11
Taro Pharma Enters into Licensing Agreement with Crescita Therapeutics 12
Crescita Therapeutics Enters into Licesning Agreement with US Contract Research Company 13
Dermatological Contract Research Company Enters into Licensing Agreement with Crescita Therapeutics 14
Knight Therapeutics Enters into Licensing Agreement with INTEGA Skin Sciences 15
Crescita Therapeutics Raises USD3.7 Million in Rights Offering of Shares 16
Crescita Therapeutics Raises USD0.7 Million in Private Placement of 9% Convertible Debenture 17
Crescita Therapeutics Divests Manufacturing Facility in Germany 18
Knight Therapeutics Acquires 4% Stake in Crescita Therapeutics 19
Crescita Therapeutics Acquires Intega Skin Sciences for USD7.6 Million 20
Crescita Therapeutics Inc, Key Competitors 21
Crescita Therapeutics Inc, Key Employees 22
Crescita Therapeutics Inc, Subsidiaries 23

List of Figures
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crescita Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報(Crescita Therapeutics Inc (CTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆